Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 32203696

Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2020 May
First author
King MT

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2020 May;21(5):612-614. doi: 10.1016/S1470-2045(20)30135-2.
    note
    Source null
    related pmid
    32203697
    relationship
    Comment in
  2. citation
    Strahlenther Onkol. 2021 Jun;197(6):565-566. doi: 10.1007/s00066-021-01764-7.
    note
    Source null
    related pmid
    33763718
    relationship
    Comment in

Authors and identifiers

  1. name
    King MT
    type
    Author
  2. name
    Link EK
    type
    Author
  3. name
    Whelan TJ
    type
    Author
  4. name
    Olivotto IA
    type
    Author
  5. name
    Kunkler I
    type
    Author
  6. name
    Westenberg AH
    type
    Author
  7. name
    Gruber G
    type
    Author
  8. name
    Schofield P
    type
    Author
  9. name
    Chua BH
    type
    Author
  10. name
    BIG 3-07/TROG 07.01 trial investigators
    type
    CollectiveName
Complete bibliographic record and source provenance
authors
  1. name
    King MT
    type
    Author
  2. name
    Link EK
    type
    Author
  3. name
    Whelan TJ
    type
    Author
  4. name
    Olivotto IA
    type
    Author
  5. name
    Kunkler I
    type
    Author
  6. name
    Westenberg AH
    type
    Author
  7. name
    Gruber G
    type
    Author
  8. name
    Schofield P
    type
    Author
  9. name
    Chua BH
    type
    Author
  10. name
    BIG 3-07/TROG 07.01 trial investigators
    type
    CollectiveName
bibliography ids
  1. nci-bib-916115abbb15d4830125ae43
book metadata
content sha256
eb39d489559fbe4c907e52bcd27ac71d44d784b14a72d885bee3ff842628282f
document type
citation
dois
  1. 10.1016/S1470-2045(20)30085-1
electronic publication date
display
2020 Mar 20
precision
day
year
2020
evidence scope
bibliographic_metadata_only
id
pubmed:32203696
immutable id
pubmed:32203696@eb39d489559fbe4c907e52bcd27ac71d44d784b14a72d885bee3ff842628282f
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
5
name
The Lancet. Oncology
nlm unique id
100957246
pages
685-698
volume
21
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2020 May;21(5):612-614. doi: 10.1016/S1470-2045(20)30135-2.
    note
    Source null
    related pmid
    32203697
    relationship
    Comment in
  2. citation
    Strahlenther Onkol. 2021 Jun;197(6):565-566. doi: 10.1007/s00066-021-01764-7.
    note
    Source null
    related pmid
    33763718
    relationship
    Comment in
outcomes validated
false
pmid
32203696
provenance
batch id
40d9eae1f1d369f13109
provider
NCBI PubMed ESummary
record sha256
df8c6a0400eb5c793b35e2b0edfae1193e3877ff1fa985dbbbbfc30854f97cba
response sha256
03fa1567b6babd78281d8ec4529596b9d4953c2c4ac23257dca371d609645ba9
retrieved at
2026-09-09T23:47:52.637547+00:00
publication date
display
2020 May
precision
month
year
2020
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Randomized Controlled Trial
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/32203696/
title
Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial.

Preserved source evidence · Not medical advice